[Sponsored Report] Tablets help alleviate PMS pain

Home > Business > Industry

print dictionary print

[Sponsored Report] Tablets help alleviate PMS pain

테스트

Prefemin tablets help to reduce premenstrual pain. Provided by the company

Premenstrual syndrome, commonly referred to as PMS, affects about 40 percent of women worldwide. Many physical symptoms, including breast pain, abdominal inflation, headache, muscular pain, weight gain, acne, constipation and fatigue, or psychological symptoms like neurosis, depression, lethargy and nervousness appear seven to 10 days before menstruation.

Behavioral changes such as decreased concentration, appetite, enthusiasm as well as drowsiness add to the list of premenstrual discomfort. These disappear with a woman’s period, but they eventually come back again at the progestational stage.

Although many women suffer from PMS pain, there is no definite remedy to it. Light symptoms get better by warming up the body or resting, but severe pain must be dealt with by professional medical staff. However, most women do not consider their symptoms to be a disease and simply take painkillers to deal with them.

Chong Kun Dang, a local pharmaceutical company, started importing and selling a herbal remedy for premenstrual symptoms, Prefemin. Zeller, a Swiss pharmaceutical company extracted the ingredients from a fruit called agnus castus. The drug is approved by the European Medicines Agency. For the patient’s convenience, the dosage is set to the minimal intake possible, a pill a day.

“Prefemin will change the notion that premenstrual syndrome does not need treatment,“ said a Chong Kun Dang official. “We hope to change the lives of women who had to deal with physical and psychological pain without proper medical care.”

By Kim Young-shin, yskim11@joongang.co.kr



More in Industry

Robofork

Big business recoils at new legal legislation

Hyundai Mobis has developed a hydrogen-powered forklift

Asiana adapts passenger plane to carry more cargo

Eastar Jet CEO threatens to sue pilot union for libel

Log in to Twitter or Facebook account to connect
with the Korea JoongAng Daily
help-image Social comment?
lock icon

To write comments, please log in to one of the accounts.

Standards Board Policy (0/250자)

What’s Popular Now